Stock Analysis

At UK£17.31, Is It Time To Put RHI Magnesita N.V. (LON:RHIM) On Your Watch List?

LSE:RHIM
Source: Shutterstock

RHI Magnesita N.V. (LON:RHIM), is not the largest company out there, but it saw significant share price movement during recent months on the LSE, rising to highs of UK£23.16 and falling to the lows of UK£17.29. Some share price movements can give investors a better opportunity to enter into the stock, and potentially buy at a lower price. A question to answer is whether RHI Magnesita's current trading price of UK£17.31 reflective of the actual value of the small-cap? Or is it currently undervalued, providing us with the opportunity to buy? Let’s take a look at RHI Magnesita’s outlook and value based on the most recent financial data to see if there are any catalysts for a price change.

See our latest analysis for RHI Magnesita

What Is RHI Magnesita Worth?

Good news, investors! RHI Magnesita is still a bargain right now according to my price multiple model, which compares the company's price-to-earnings ratio to the industry average. I’ve used the price-to-earnings ratio in this instance because there’s not enough visibility to forecast its cash flows. The stock’s ratio of 3.73x is currently well-below the industry average of 8.74x, meaning that it is trading at a cheaper price relative to its peers. Although, there may be another chance to buy again in the future. This is because RHI Magnesita’s beta (a measure of share price volatility) is high, meaning its price movements will be exaggerated relative to the rest of the market. If the market is bearish, the company’s shares will likely fall by more than the rest of the market, providing a prime buying opportunity.

What does the future of RHI Magnesita look like?

earnings-and-revenue-growth
LSE:RHIM Earnings and Revenue Growth September 29th 2022

Investors looking for growth in their portfolio may want to consider the prospects of a company before buying its shares. Although value investors would argue that it’s the intrinsic value relative to the price that matter the most, a more compelling investment thesis would be high growth potential at a cheap price. However, with a relatively muted profit growth of 1.1% expected over the next couple of years, growth doesn’t seem like a key driver for a buy decision for RHI Magnesita, at least in the short term.

What This Means For You

Are you a shareholder? Even though growth is relatively muted, since RHIM is currently trading below the industry PE ratio, it may be a great time to accumulate more of your holdings in the stock. However, there are also other factors such as financial health to consider, which could explain the current price multiple.

Are you a potential investor? If you’ve been keeping an eye on RHIM for a while, now might be the time to enter the stock. Its future profit outlook isn’t fully reflected in the current share price yet, which means it’s not too late to buy RHIM. But before you make any investment decisions, consider other factors such as the strength of its balance sheet, in order to make a well-informed assessment.

So while earnings quality is important, it's equally important to consider the risks facing RHI Magnesita at this point in time. For example, we've found that RHI Magnesita has 3 warning signs (2 are significant!) that deserve your attention before going any further with your analysis.

If you are no longer interested in RHI Magnesita, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.